Middle East Healthcare Company (4009.SR)
SAR 71.8
(2.28%)
SAR 71.8
(2.28%)
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2023 | 551.23 Million SAR | 82.26% |
| 2022 | 297.41 Million SAR | 44.8% |
| 2021 | 212.89 Million SAR | -21.5% |
| 2020 | 243.82 Million SAR | 21.63% |
| 2019 | 220.73 Million SAR | 17.46% |
| 2018 | 251.68 Million SAR | -50.49% |
| 2017 | 387.89 Million SAR | -14.34% |
| 2016 | 421.96 Million SAR | -4.05% |
| 2015 | 446.73 Million SAR | 24.88% |
| 2014 | 357.72 Million SAR | 119.54% |
| 2013 | 184.2 Million SAR | 62.34% |
| 2012 | 100.37 Million SAR | 0.0% |
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2024 Q2 | 182.85 Million SAR | 3.48% |
| 2024 Q3 | 115.88 Million SAR | -36.63% |
| 2024 Q1 | 168.96 Million SAR | 25.45% |
| 2023 Q3 | 159.33 Million SAR | 32.03% |
| 2023 Q4 | 136.75 Million SAR | -14.17% |
| 2023 FY | - SAR | 82.26% |
| 2023 Q1 | 126.14 Million SAR | 35.77% |
| 2023 Q2 | 120.67 Million SAR | -4.33% |
| 2022 FY | - SAR | 44.8% |
| 2022 Q4 | 92.9 Million SAR | 208.49% |
| 2022 Q3 | 30.11 Million SAR | 8.26% |
| 2022 Q2 | 27.81 Million SAR | -60.58% |
| 2022 Q1 | 70.57 Million SAR | 150.96% |
| 2021 FY | - SAR | -21.5% |
| 2021 Q2 | 55.09 Million SAR | -2.15% |
| 2021 Q3 | 62.63 Million SAR | 13.68% |
| 2021 Q4 | 28.12 Million SAR | -55.1% |
| 2021 Q1 | 56.31 Million SAR | -18.97% |
| 2020 Q2 | 58.52 Million SAR | 10.91% |
| 2020 FY | - SAR | 21.63% |
| 2020 Q3 | 77.22 Million SAR | 31.97% |
| 2020 Q4 | 69.49 Million SAR | -10.01% |
| 2020 Q1 | 52.76 Million SAR | -22.73% |
| 2019 Q3 | 62.19 Million SAR | 52.62% |
| 2019 FY | - SAR | 17.46% |
| 2019 Q4 | 68.28 Million SAR | 9.79% |
| 2019 Q2 | 40.75 Million SAR | -4.05% |
| 2019 Q1 | 42.47 Million SAR | 20.26% |
| 2018 Q3 | 45.89 Million SAR | 30.98% |
| 2018 Q1 | 88.32 Million SAR | 21.98% |
| 2018 FY | - SAR | -50.49% |
| 2018 Q4 | 35.32 Million SAR | -23.03% |
| 2018 Q2 | 35.03 Million SAR | -60.33% |
| 2017 FY | - SAR | -14.34% |
| 2017 Q2 | 179.03 Million SAR | -15.09% |
| 2017 Q1 | 210.83 Million SAR | 101.95% |
| 2017 Q3 | 55.01 Million SAR | -69.27% |
| 2017 Q4 | 72.4 Million SAR | 31.62% |
| 2016 FY | - SAR | -4.05% |
| 2016 Q2 | 212.09 Million SAR | -2.05% |
| 2016 Q3 | 98.54 Million SAR | -53.54% |
| 2016 Q4 | 104.39 Million SAR | 5.94% |
| 2016 Q1 | 216.53 Million SAR | 85.59% |
| 2015 Q4 | 116.67 Million SAR | 24.46% |
| 2015 FY | - SAR | 24.88% |
| 2015 Q1 | 208.99 Million SAR | 131.66% |
| 2015 Q3 | 93.74 Million SAR | -54.02% |
| 2015 Q2 | 203.87 Million SAR | -2.45% |
| 2014 Q3 | 83.11 Million SAR | 0.0% |
| 2014 Q4 | 90.21 Million SAR | 8.55% |
| 2014 FY | - SAR | 119.54% |
| 2014 Q1 | 85.35 Million SAR | 0.0% |
| 2013 FY | - SAR | 62.34% |
| 2012 FY | - SAR | 0.0% |
| Name | EBITDA | EBITDA Difference |
|---|---|---|
| Mouwasat Medical Services Company | 986.81 Million SAR | 44.14% |
| Dallah Healthcare Company | 631.92 Million SAR | 12.769% |
| National Medical Care Company | 323.02 Million SAR | -70.651% |
| Al Hammadi Company For Development and Investment | 438.27 Million SAR | -25.773% |
| Dr. Sulaiman Al Habib Medical Services Group Company | 2.54 Billion SAR | 78.335% |
| Canadian General Medical Center Complex Company | 19.92 Million SAR | -2666.777% |
| Arabian International Healthcare Holding Company | 111.1 Million SAR | -396.135% |
| Future Care Trading Co. | 15.6 Million SAR | -3431.743% |
| Naba Alsaha Medical Services Company | 65.27 Million SAR | -744.431% |
| Lana Medical Co. | 4.56 Million SAR | -11968.909% |
| Al-Modawat Specialized Medical Co. | 20.76 Million SAR | -2554.205% |